An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.


Updates from The Motley Fool

Latest updates on Alexza Pharmaceuticals from Fool.com.


Stock Performance

ALXA vs. S&P 500 | 2 Year Performance
View Interactive ALXA Charts
Sponsored by

Key Data Points

Primary metrics and data points about Alexza Pharmaceuticals.
Current Price: $0.00
Prev Close: $0.00
Open: $0.00
Bid: $0.00
Ask: $0.00
Day's Range: $0.00 - $0.00
52wk Range: $0.00 - $0.00
Volume: 0
Avg Vol 0
Market Cap: $0.00
P/E (ttm): 0.00
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Alexza Pharmaceuticals.
CAPS Rating 2 out of 5
 
148 Outperform
16 Underperform
CAPS All Stars
 
25 Outperform
5 Underperform

How do you think Alexza Pharmaceuticals will perform against the market?



You pick for Alexza Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Thomas B. King, CEO

86% Approve

Based on 11 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Alexza Pharmaceuticals.

An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.

  • Exchange: NASDAQOTH
  • Sector: Healthcare
  • Industry: Drug Makers